1. Introduction
===============

Pregnancy and childbirth is the most intense and most stressful time of a woman's life, and is always considered one of the main life-threatening factors of their life. Thus, in these risky and stressful periods, women need high-quality care and additional support ([@b1-epj-09-6002]). The mechanism of childbirth is a spontaneous process and without need to the intervention ([@b2-epj-09-6002]) that this action takes places both cesarean and vaginal childbirth ([@b3-epj-09-6002]). Vaginal childbirth is known as the best method of childbirth but unfortunately, in recent years the prevalence of this type of childbirth, due to the spread and popularity of cesarean, has reduced and this has become one of the serious concerns of health authorities ([@b4-epj-09-6002]). One of the main reasons for the decline of natural childbirth is the amount of pain in natural childbirth ([@b5-epj-09-6002]--[@b7-epj-09-6002]). For this purpose, researchers in recent years have made great efforts for the development of natural childbirth methods without pain ([@b8-epj-09-6002]). In no-pain childbirth, midwives and physicians using different methods try to reduce natural childbirth pain for the mother, so that she can give birth more easily and with less pain and suffering ([@b9-epj-09-6002]). There are many ways to reduce child birth pain ([@b10-epj-09-6002]--[@b15-epj-09-6002]). One of the methods is the use of analgesic gas of Entonox. Entonox is a mixture of oxygen gas and nitrous oxide (N~2~O) and is prescribed through a mask. When during childbirth, she feels uterine contraction as pain, the mask is placed on the mother's face and the mother takes deep breaths through it. Gas enters into the lungs and then to the brain and by effecting the brain's pain centers, reduces the feeling of pain ([@b16-epj-09-6002]--[@b20-epj-09-6002]). In recent years, some studies in Iran investigated the effect of using Entonox in reducing pain and other childbirth indicators ([@b21-epj-09-6002], [@b22-epj-09-6002]). However, these studies investigated the impact of using Entonox in a small environment and have a smaller sample size. So, transparent and useful information for decision-making and policy at the macro level could not be provided. A systematic summary of results of these studies can provide necessary information to make decisions and policies at the macro level. So, the purpose of this study was to conduct a systematic review and meta-analysis of the effect of using Entonox in pain relief and other indicators of childbirth.

2. Material and Methods
=======================

2.1. Research design and search strategy
----------------------------------------

This systematic review and meta-analysis study was designed and conducted in 2016 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) approach ([@b23-epj-09-6002]--[@b25-epj-09-6002]). The required data was collected using keywords such as "Entonox", "nitrous oxide", "vaginal delivery", "pain relief", "obstetric", "labor pain", and "labor analgesia", from databases including Google scholar, PubMed, Science Direct, Magiran, SID and Scopus, and hand-searching of related and valid journals and references of articles. Articles published from 2000 to 2016 were searched.

2.2. Inclusion and exclusion criteria
-------------------------------------

The inclusion criteria for entering the articles included: participants including mothers and their infants, intervention included "Entonox" or "nitrous oxide", comparison included other options for pain relief in labor or non-intervention groups, outcome included Apgar score, pain relief and mothers' satisfaction rate. Published articles in English or Persian language and interventional studies were also included in the study. The exclusion criteria consisted of: studies that had no control group, conference and meeting articles, case reports, letters to editors and educational articles.

2.3. Quality assessment
-----------------------

The quality of articles was assessment by two researchers using a checklist of stands for Consolidated Standards of Reporting Trials (CONSORT: 2010). The CONSORT evaluating tool is one of the most important and applicable tools for evaluating clinical trial articles, and was introduced in the mid-1990s by a group of experts in clinical trials, statisticians, and epidemiologists as an international strategy and a standard method for reporting clinical trials. Based on the latest version of the checklist's instruction, CONSORT 2010 includes 37 items for evaluating 6 main parts of clinical trial studies. These 6 parts are title and abstract, introduction, materials and methods, results, discussion, and other information.

2.4. Data extraction
--------------------

For extraction of data, in first phase a data extraction table form was developed in Excel: 2010 office software. This extraction table included the following data: name of author, article publication year, sample size, Apgar score, pain relief and mother's satisfaction rate. In the second phase of data, 5 articles were extracted by this form and the problems in the initial form were eliminated. After the extraction table was finalized, required data from selected articles were extracted and summarized in tables.

2.5. Data analysis
------------------

In order to estimate Apgar score mean, pain relief mean and mothers' satisfaction rate between Entonox and comparison groups, meta-analysis statistical methods were applied. To conduct meta-analysis, CMA:2 (Comprehensive Meta-analysis) was used. To report the results, the forest plot diagrams were used with 95 percent for each study. For evaluation of heterogeneity among the studies' results, Q statistic and I^2^ indicator were used. In the current study, I^2^ more than 50% was determined as criterion of heterogeneity.

3. Results
==========

Out of 296 articles which have been found from literature, finally 14 articles related to the aim of the study were included in the study ([Figure 1](#f1-epj-09-6002){ref-type="fig"}). Characteristics of included articles' results are summarized in Table1. In the analysis phase of effect of Entonox in pain relief, the result of a Khadem N, et al. ([@b37-epj-09-6002]) study, due to high heterogeneity, was not included in meta-analysis. According to results of included studies to analysis, the pain relief standard difference in mean between groups was −1.01 (95% CI: −1.59 to −0.43, Q=148.5, df=8, p=0.02, I^2^= 76) ([Figure 2](#f2-epj-09-6002){ref-type="fig"}), this difference was significant (p\<0.05). The overall Apgar score standard difference in mean between groups (Entonox vs. comparison) was 0.12 (95% CI: 0.01 to 0.23, Q=109.4, df=16, p=0.00, I^2^= 85.3), this difference was significant (p\<0.05). Difference between groups in five-minute Apgar was 0.06 (95% CI: −0.06 to 0.17, Q=235.6, df=7, p=0.00, I^2^= 89.3), this difference was not significant (p\>0.05). Difference between groups in one-minute Apgar was 0.47 (95% CI: 0.19 to 0.76, Q=413.7, df=8, p=0.00, I^2^= 97.3), this difference was significant (p\<0.05) ([Figure 3](#f3-epj-09-6002){ref-type="fig"}). The results of mothers' satisfaction rate show that, 57.6% of mothers in Entonox group have a high level of satisfaction rate vase 21.3% of mothers in comparison group. To evaluate publication bias, a funnel plot was applied ([Figure 4](#f4-epj-09-6002){ref-type="fig"}). Results of this funnel plot show that there was a possibility of publication bias among the studies.

4. Discussion
=============

Pain relief standard difference in mean between groups was significantly different (p\<0.05). The results of mothers' satisfaction rate show that, mothers in Entonox have a high level of satisfaction rate. The results showed Entonox has a significant effect in reducing childbirth pain. According to the study of the College of Obstetrics and Gynecology of Australia in New Zealand, around 70 percent of women have had pain relief with Entonox ([@b26-epj-09-6002]). In a study by Soyannow et al. that was conducted on 150 Nigerian women, it was shown that Entonox has significant effect in reducing childbirth pain ([@b27-epj-09-6002]). In a research conducted by Rosen on 400 pregnant women in America in 2004, it showed that Entonox is significantly effective in reducing childbirth pain ([@b28-epj-09-6002]). Despite the availability of other methods to reduce childbirth pain, for three main reasons Entonox is one of the most widely used methods. These three reasons include: rapid elimination from the body, absence of expensive, complex equipment and specialized personnel and finally, the general well-being and satisfaction of the mother, although the administration should be under the supervision of trained personnel ([@b20-epj-09-6002]). Results of this study showed that Apgar score of babies whose mothers used Entonox gas during childbirth was significantly better than comparison groups. Results of different studies have also shown that Apgar score of babies whose mothers used Entonox gas during childbirth was better than comparison groups ([@b21-epj-09-6002], [@b29-epj-09-6002]). In the research of Volmanen in 2005, the results did not show a significant difference between Apgar score of babies whose mothers had used the Entonox compared with Apgar score of babies whose mothers had used remifentanil ([@b30-epj-09-6002]). Considering the impact of pain on reducing blood supply to the mother's womb and fetus, more Apgar score of babies in Entonox method according to further reduce of the mother's pain is justified. The results showed that the mother in the Entonox group in comparison with other methods of reducing childbirth pain, had a higher level of satisfaction. Dann et al reported that 96.8 percent of those who used Entonox to induce analgesia in childbirth again had the tendency to use Entonox ([@b31-epj-09-6002]). Rosen also, in his review study, has noted that childbirth satisfaction with reducing pain and lack of severe side effects has had a positive correlation. He reported the desire to reuse Entonox in future childbirth in 80 %of those who had used the gas ([@b32-epj-09-6002]). The use of pain relief methods to ease childbirth pain is common in most countries. Eighty-one percent of women who give birth in the United States used one of the methods of drug analgesia, and 19% of others used a large number of non-pharmacological methods; in European countries, this figure reaches 90%. Despite the simple and available methods of painless childbirth, it seems that using these methods in Iran, due to the lack of knowledge of the benefits and possible side effects of these methods, are not common. According to World Health Organization recommendations and policies of the Ministry of Health, Treatment and Medical Education in order to reduce the rate of cesarean without medical indication of mothers to be encouraged to natural childbirth and while they are deprived of the benefits of painless natural childbirth. The mean limitation of this study was lack of access to detailed data in some papers. Because some papers did not report detailed results, extracting the intended data from those papers was impossible. Future studies in this area should consider this issue when conducting and reporting the study.

5. Conclusions
==============

Based on the results of the study published in Iran that are investigated in the present study, it can be said that the use of Entonox gas is an effective method for reducing the amount of childbirth pain, and in addition to reducing pain, the Apgar score and satisfaction in women also has positive results. Therefore, given the high rate of cesarean in Iran, which, it appears, one of the reasons is the fear of natural childbirth pain, development of painless childbirth methods such as using Entonox, can have a positive effect in reducing cesarean.
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Characteristics of included articles

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Ref. no.                                Sample size   Apgar                Pain relief (VAS)   Satisfaction rate                                                                                
  --------------------------------------- ------------- -------------------- ------------------- ------------------- ----------------------------- ---------------------------- ----------------- ------------------
  [@b33-epj-09-6002]                      80            Oxygen=80            M1=8.71±0.4         M1=8.57±0.6         \-                            \-                           High=71.2\        High=16.9\
                                                                                                                                                                                Moderate=23.4\    Moderate=32.5\
                                                                                                                                                                                Low=4.1\          Low=28.6\
                                                                                                                                                                                Unsatisfied=1.3   Unsatisfied=22

  [@b34-epj-09-6002]                      50            Pethidine=50         \-                  \-                  Before analgesia=9.1±0.9\     Before analgesia=9.4±0.7\    High=46\          High=28\
                                                                                                                     Over first stage=6±1.5\       Over first stage=7.1±1.2\    Moderate=32\      Moderate=36\
                                                                                                                     Over second stage=5.7±1.8\    Over second stage=8.2±1\     Low=20\           Low=28\
                                                                                                                     Mean±SD:6.9±1.4               Mean± SD: 8.3±0.9            Unsatisfied=2     Unsatisfied=8

  [@b35-epj-09-6002]                      49            No intervention=45   \-                  \-                  \-                            \-                           High=49\          High=22.4\
                                                                                                                                                                                Moderate=28.6\    Moderate=42.9\
                                                                                                                                                                                Low=20.4\         Low=24.5\
                                                                                                                                                                                Unsatisfied=2     Unsatisfied=10.2

  [@b36-epj-09-6002]                      76            Oxygen=94            \-                  \-                  5.1±1.2                       8.9±1.9                      \-                \-

  [@b37-epj-09-6002]                      42            Epidural=42          M1=8.4\             M1=8.5\             Before analgesia=5.8\         Before analgesia=1.2\        \-                \-
                                                                             M5=8.8              M5=8.8              Over first stage=7.7\         Over first stage=1.5\                          
                                                                                                                     Over second stage=9.5\        Over second stage=1.6\                         
                                                                                                                     Mean±SD:7.6                   Mean±SD:1.4                                    

  [@b38-epj-09-6002]                      50            Pethidine=50         M1=9±0.3\           M1=8±0.9\           Before analgesia=7.3±2\       Before analgesia=7.3±1.1\                      
                                                                             M5=9.9±0.4          M5=9.8±0.2          Over first stage=3.9±1.4\     Over first stage=5.6±1.1\                      
                                                                                                                     Over second stage=5±1.4\      Over second stage=4.7±1.1\                     
                                                                                                                     Mean±SD:5.7±1.6               Mean±SD:5.8±1.1                                

  [@b39-epj-09-6002]                      50            No intervention=50   M1=9.1±0.3\         M1=8.9±0.3\         5.3±1.2                       6.9±1.8                      \-                \-
                                                                             M5=9.9±0.3          M5=9.8±0.6                                                                                       

  [@b40-epj-09-6002]                      135           No intervention=\    M1=9±0.7\           M1=9.1±0.6\         \-                            \-                           \-                \-
                                                        135                  M5=9.7±0.4          M5=9.8±0.4                                                                                       

  [@b41-epj-09-6002]                      100           No intervention=\    M1=9.1\             M1=8.9\             5±1.6                         8.8±1.6                      High=64\          High=18\
                                                        100                  M5=9.8              M5=9.7                                                                         Moderate=25\      Moderate=30\
                                                                                                                                                                                Low=7\            Low=27\
                                                                                                                                                                                Unsatisfied=4     Unsatisfied=25

  [@b42-epj-09-6002]                      30            No intervention=30   \-                  \-                  5.6±1.5                       7.8±3.8                      \-                \-

  [@b43-epj-09-6002]                      60            Oxygen=60            \-                  \-                  5.8±1.9                       6.8±2.1                      \-                \-

  [@b44-epj-09-6002], [@b1-epj-09-6002]   50            Warm water=50        M1=9.2±0.5\         M1=8.8±0.3\         Before analgesia=6.3±1.7\     Before analgesia=6.6±1.5\    \-                \-
                                                                             M5=10±0.5           M5=10±0.5           Over first stage=4.8±1.8\     Over first stage=5.7±1.8\                      
                                                                                                                     Over second stage=4.32±1.6\   Over second stage=6.4±2\                       
                                                                                                                     Mean±SD:5.1±1.7               Mean±SD:6.2±1.7                                

  [@b44-epj-09-6002], [@b2-epj-09-6002]   50            No intervention=50   M1=9.2±0.5\         M1=8.7±0.6\         Before analgesia=6.3±1.7\     Before analgesia=4.8±0.9\    \-                \-
                                                                             M5=10±0.5           M5=10±0.5           Over first stage=4.8±1.8\     Over first stage=5.4±1.1\                      
                                                                                                                     Over second stage=4.32±1.6\   Over second stage=7.4±1.1\                     
                                                                                                                     Mean±SD:5.1±1.7               Mean±SD:5.4±1                                  

  [@b45-epj-09-6002]                      250           No intervention=\    M1=8.5±0.9\         M1=8.5±0.8\         \-                            \-                           \-                \-
                                                        250                  M5=9.5±0.8          M5=9.5±0.7                                                                                       
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

VAS= visual analog scale; M1= minute one; M5= minute five
